Inbrain Neuroelectronics Secures $17 Million In Series A Funding For First Ai-Powered Graphene-Brain Interface
Inbrain Neuroelectronics Secures $17 Million In Series A Funding For First Ai-Powered Graphene-Brain Interface
03/30/21, 11:08 AM
Location
barcelonaMoney raised
$17 million
Round Type
series a
INBRAIN Neuroelectronics S.L., a company in the intersection between Medtech, Deeptech and Digital Health dedicated to developing the world’s first intelligent graphene-brain interface, today announced $16.8 million in Series A funding for its disruptive system for treating epilepsy and Parkinson’s disease.
Company Info
Company
Inbrain Neuroelectronics
Location
barcelona, catalonia, spain
Additional Info
INBRAIN Neuroelectronics S.L., founded in 2019, is a medical device company dedicated to developing the world’s first intelligent graphene-brain interface to treat a variety of conditions. INBRAIN’s first product is designed to read and modulate brain activity, using artificial intelligence to trigger adaptive responses for personalized neurological therapy for epilepsy and Parkinson’s disease. For more information, please visit www.inbrain-neuroelectronics.com.